<DOC>
	<DOC>NCT02613312</DOC>
	<brief_summary>The purpose of this study is to determine the response rate and overall survival in patients that have been diagnosed with mesothelioma and will undergo chemotherapy, surgery and intensity modified radiation therapy (IMRT) as part of their standard of care.</brief_summary>
	<brief_title>Chemotherapy Followed by Surgery and Neoadjuvant Hemothoracic Intensity Modified Radiation Therapy (IMRT) for Patients With Malignant Pleural Mesothelioma</brief_title>
	<detailed_description>The investigators will consent patients that have been diagnosed with mesothelioma and will undergo chemotherapy followed by surgery and then IMRT as their standard of care. The investigators will collect data from past and future medical records as well as data regarding their health status for their lifetime by reviewing life status, treatment status and CT scans.</detailed_description>
	<mesh_term>Mesothelioma</mesh_term>
	<mesh_term>Neoplasms, Fibrous Tissue</mesh_term>
	<mesh_term>Solitary Fibrous Tumors</mesh_term>
	<mesh_term>Solitary Fibrous Tumor, Pleural</mesh_term>
	<mesh_term>Pleural Neoplasms</mesh_term>
	<criteria>Subject provides informed consent Subject is &gt;18 years of age Subject is deemed competent for making medical decisions Subject is scheduled to undergo chemotherapy followed by surgery and then IMRT Subject is a surgical candidate A negative pregnancy test is required in women of childbearing potential, as standard of care. â€¢Subject is &lt;18 years old.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>